Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Pinder

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancerMichael A Gonzalez, Sarah E Pinder, Grace Callagy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic IndexGrace M Callagy, Paul D Pharoah, Sarah E Pinder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breastFrances P O'Malley, Syed K Mohsin, Sunil Badve, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2013
Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profilesPatrycja Gazinska, Anita Grigoriadis, John P Brown, et al.
Histopathology|January 15, 2015
Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approachesSarah E Pinder, Emad A Rakha, Colin A Purdie, et al.
NMR in Biomedicine|December 22, 2016
Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo studyColleen Bailey, Bernard Siow, Eleftheria Panagiotaki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 28, 2004
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysisThomas C Putti, Dalia M Abd El-Rehim, Emad A Rakha, et al.
Journal of Clinical Pathology|December 13, 2006
MYC amplification in breast cancer: a chromogenic in situ hybridisation studyS Maria Rodriguez-Pinilla, Robin L Jones, Maryou B K Lambros, et al.
Histopathology|December 22, 2016
Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?Michael S Toss, Sarah E Pinder, Andrew R Green, et al.
The Journal of Pathology|August 14, 2023
Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospectsGregory Verghese, Jochen K Lennerz, Danny Ruta, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancerMichael A Gonzalez, Sarah E Pinder, Grace Callagy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic IndexGrace M Callagy, Paul D Pharoah, Sarah E Pinder, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 21, 2006
Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breastFrances P O'Malley, Syed K Mohsin, Sunil Badve, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 9, 2013
Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profilesPatrycja Gazinska, Anita Grigoriadis, John P Brown, et al.
Histopathology|January 15, 2015
Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approachesSarah E Pinder, Emad A Rakha, Colin A Purdie, et al.
NMR in Biomedicine|December 22, 2016
Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo studyColleen Bailey, Bernard Siow, Eleftheria Panagiotaki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 28, 2004
Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysisThomas C Putti, Dalia M Abd El-Rehim, Emad A Rakha, et al.
Journal of Clinical Pathology|December 13, 2006
MYC amplification in breast cancer: a chromogenic in situ hybridisation studyS Maria Rodriguez-Pinilla, Robin L Jones, Maryou B K Lambros, et al.
Histopathology|December 22, 2016
Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?Michael S Toss, Sarah E Pinder, Andrew R Green, et al.
The Journal of Pathology|August 14, 2023
Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospectsGregory Verghese, Jochen K Lennerz, Danny Ruta, et al.
Pageof 15